Skip to main content
. 2021 Aug 19;62(1):187–193. doi: 10.1016/j.japh.2021.08.015

Table 2.

Responses to patient perception survey of pharmacist-guided point-of-care COVID-19 testing and counseling (n = 622)

Parameter
Response, n (%)
Survey question Strongly agree Agree Disagree Strongly disagree Declined to answer
Q1. I felt comfortable going to a community pharmacy to receive testing for COVID-19 infection. 399 (64.2) 219 (35.2) 4 (0.6) 0 0
Q2. Having a testing center at a community pharmacy improved my access to health care services. 385 (61.9) 222 (35.7) 13 (2.1) 2 (0.3) 0
Q3. After my conversation with the pharmacist, I felt more knowledgeable about managing coronavirus signs and symptoms. 288 (46.3) 272 (43.7) 55 (8.8) 7 (1.1) 0
Q4. After my conversation with the pharmacist, I felt more knowledgeable about knowing when to seek medical attention for potential COVID-19 symptoms. 289 (46.5) 259 (41.6) 67 (10.8) 7 (1.1) 0
Q5. My test results were reported to me in a timely manner. 412 (66.2) 194 (31.2) 10 (1.6) 5 (0.8) 1 (0.2)
Q6. Pharmacist-provided testing services benefit my community. 385 (61.9) 226 (36.3) 8 (1.3) 0 2 (0.3)
Q7. Overall, I am satisfied with the testing services I received. 420 (67.5) 197 (31.7) 3 (0.4) 2 (0.3) 0
Q8. I would be willing to receive a pharmacist-provided test for COVID-19 infection at a community pharmacy again. 406 (65.3) 203 (32.6) 7 (1.1) 0 6 (1.0)

Abbreviations used: COVID-19, coronavirus disease; Q, question.